C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2004
12/09/2004	US20040248116 Using cancer marker gene expression patterns to diagnose, classify and prognosticate cell proliferative disorders
12/09/2004	US20040248115 Nucleotide sequence probes for detecting beer-spoilage lactic acid bacteria; food processing and alcoholic beverages
12/09/2004	US20040248113 Expression vector comprising immunoglobulin sequences for treatment and prevention of infections and cell proliferative disorders; minigene vaccines; immunotherapy
12/09/2004	US20040248112 Isolated human transporter proteins nucleic acid molecules encoding human transporter proteins and uses thereof
12/09/2004	US20040248091 Novel polypeptide-human g-protein and the polynucleotide encoding the same
12/09/2004	US20040248088 Novel g protein-coupled receptor up-regulated in prostate cancer and uses thereof
12/09/2004	US20040248081 Composition comprising latency-associated nuclear antigen (LANA) for use in identifying modulators which prevent viral association with genomic nucleotide sequences; treating viral infections and cell proliferative disorders; viricides
12/09/2004	US20040247691 wound healing and tissue forming compositions with suitable cells affixed to prosthetic devices; microbeads are prepared by coagulation and emulsification of fibrinogen, thrombin and factor XIII without gluteraldehyde as a crosslinking agent
12/09/2004	US20040247617 Fusion antigen used as vaccine
12/09/2004	US20040247616 Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof
12/09/2004	US20040247615 A nucleic acid comprising a nucleotide sequence encoding a Met-NS3-NS4A-NS4B-NS5A-NS5B polypeptide containing an inactive NS5B RNA-dependent RNA polymerase region; adenovector or DNA plasmid vaccine; cultured cells expressing the nucleic acid; vaccination
12/09/2004	US20040247614 Lysine-acyetylated tat proteins of a human immunodeficiency virus; specifically binding antibodies; vaccination to inhibit transcriptional activation
12/09/2004	US20040247612 Immunogenic peptide composition for the prevention and treatment of Alzheimer's Disease
12/09/2004	US20040247611 Immunoassay for identifying pathogen-ligand interactions under shear conditions; vaccines containing an anti-adhesive monoclonal antibody, an adhesive peptide, or a pathogen adhesin
12/09/2004	US20040247610 A lysine-glycine-lysine-glycine-Xaa pentapeptide residue complexed with one or more B-cell or T-cell determinants and targeting molecules; influenza type A vaccinations
12/09/2004	US20040247608 The hapten moieties are attached, directly or indirectly, to lysines of the monomeric units of the carrier; particularly an aggregated STn-KLH conjugate; used particularly for cancer immunotherapy
12/09/2004	US20040247603 Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation
12/09/2004	US20040247601 Methods for diagnosing cancer and decreasing metastasis by cancer cells
12/09/2004	US20040247596 TRANCE regulation of chondrocyte differentiation
12/09/2004	US20040247595 Related to the potassium channel subfamily; can be used as models for the development of and aid in the identification of therapeutic proteins that modulate transporter activity
12/09/2004	US20040247586 Parkin-associated complex for protecting post-mitotic neurons from excitotoxicity and uses thereof
12/09/2004	US20040247566 Having at least one amino-acid substitution and including multimers and Fc-fusion constructs; treating a human lung disorder such as chronic obstructive pulmonary disorder, asthma, emphysema, and chronic bronchitis
12/09/2004	US20040247562 Diagnostic and prognostic method for cancer based on skipping of the exon 3 region of the G-CSF gene at mRNA or protein levels
12/09/2004	US20040247555 Methods of and compositions for modulating hair growth via P-cadherin modulators
12/09/2004	US20040247537 Uv-screening peptide-flavonoid conjugates
12/09/2004	US20040244969 Methods of well treatment
12/09/2004	US20040244714 Methods for growing and imprinting fish using an odorant
12/09/2004	US20040244623 Printed materials comprising a support having an oligomer and/or a polymer applied thereon, a method for preparing the same and a method for delivering and/or storing the same
12/09/2004	DE10322044A1 Thioredoxin-Peroxidase von C. albicans als virulenzspezifischer Marker Thioredoxin peroxidase of C. albicans as virulenzspezifischer marker
12/09/2004	DE10314413A1 Verfahren zum Nachweis der Expression rekombinanter Proteine an einer Zelloberfläche und zur Immobilisierung und Aufreinigung von Zellen und Proteinen A method for detecting the expression of recombinant proteins on a cell surface and for immobilization and purification of proteins and cells
12/09/2004	CA2527571A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
12/09/2004	CA2527309A1 Use of protein associated with mye (pam) to treat pain
12/09/2004	CA2527296A1 Imageable animal model of sars infection
12/09/2004	CA2527179A1 Ecdysone receptor ligand-binding domain structure
12/09/2004	CA2526623A1 Soluble clca-1 and antagonists to clca-1
12/09/2004	CA2526083A1 Complement inhibitors
12/09/2004	CA2525717A1 Gitr ligand and gitr ligand-related molecules and antibodies and uses thereof
12/09/2004	CA2525540A1 Enterococcus antigens
12/09/2004	CA2523774A1 Deer antler extract for promoting angiogenesis
12/09/2004	CA2521331A1 Novel il-8-like polypeptides
12/09/2004	CA2519835A1 Method of treating corneal transplant rejection
12/08/2004	EP1484411A1 Stress resistant plant
12/08/2004	EP1484405A1 Nucleic acid fragments and polypeptide fragments derived from M. Tuberculosis
12/08/2004	EP1484404A1 Immunogenic detoxified mutants of cholera toxin and of the toxin LT, their preparation and their use for the preparation of vaccines
12/08/2004	EP1484403A1 Gene participating in the synthesis of brassinosteroid
12/08/2004	EP1484401A1 Secreted polypeptides and corresponding polynucleotides
12/08/2004	EP1484400A1 Sodium-independent transporter carrying acidic amino acid and its gene
12/08/2004	EP1484399A1 Mouse spermatogenesis genes, human male sterility-associated genes and diagnostic system using the same
12/08/2004	EP1484398A1 Human glioma antigen originating in testis
12/08/2004	EP1484397A1 Peptide from antigen MUC-1 for triggering an immune response to tumor cells
12/08/2004	EP1484396A1 Molecules associating to c-terminal domain in receptor cell
12/08/2004	EP1484391A1 Vaccine against mumps
12/08/2004	EP1484340A1 Antibodies to a novel mammalian protein associated with uncontrolled cell division
12/08/2004	EP1484339A2 Kallikrein-inhibiting "Kunitz Domain" proteins and nucleic acids encoding the same
12/08/2004	EP1484338A1 Methods and compositions for inhibiting neoplastic cell growth
12/08/2004	EP1484337A2 Methods, kits and compositions pertaining to linear beacons
12/08/2004	EP1484335A1 23 human secreted proteins
12/08/2004	EP1484080A1 Biodegradable, anionic polymers
12/08/2004	EP1484067A2 Cancer control
12/08/2004	EP1484066A1 Remedy for infections
12/08/2004	EP1483962A2 Transgenic animal model for Glyt1 function
12/08/2004	EP1483588A2 Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders
12/08/2004	EP1483575A2 Methods for isolating ligands e.g. t cell epitopes
12/08/2004	EP1483408A1 Nanostructures containing pna joining or functional elements
12/08/2004	EP1483399A2 Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolitic products
12/08/2004	EP1483397A2 Oligomeric molecules and uses thereof
12/08/2004	EP1483396A2 Wit 3.0, novel gene to control soft tissue wound healing
12/08/2004	EP1483394A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
12/08/2004	EP1483391A1 Engineered baculoviruses and their use
12/08/2004	EP1483390A2 Transgenic plants synthesising high amylose starch
12/08/2004	EP1483389A2 Genetic products differentially expressed in tumors and use thereof
12/08/2004	EP1483387A1 Process for the preparation of l-amino acids using strains of the family enterobacteriaceae
12/08/2004	EP1483386A2 Novel nucleic acids and secreted polypeptides
12/08/2004	EP1483385A2 Compositions and methods for generating an immune response
12/08/2004	EP1483384A2 Method for overexpression of zwitterionic polysaccharides
12/08/2004	EP1483372A2 Functionalization of t cell derived vesicles and use thereof for the preparation of immunogenic pharmaceutical compositions
12/08/2004	EP1483366A1 Antimicrobial composition
12/08/2004	EP1483298A2 Materials and methods for preparing dimeric growth factors
12/08/2004	EP1483289A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
12/08/2004	EP1483288A2 Hbm variants that modulate bone mass and lipid levels
12/08/2004	EP1483287A1 An infectious bursal disease virus variant
12/08/2004	EP1482984A2 Surrogate antibodies and methods of preparation and use thereof
12/08/2004	EP1482981A1 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy
12/08/2004	EP1482975A2 Prevention of tissue adhesion
12/08/2004	EP1482969A2 Purifying process of soluble proteins of the l. obliqua bristles through prothrombin activation; process for a partial determination of the amino acids sequence of the prothrombin activator; process for determining the prothrombin activation of fraction ii, n-terminal and internal fragments sequence
12/08/2004	EP1482965A2 Method to control tumor progression and invasiveness
12/08/2004	EP1482963A2 Controlled modulation of amino acid side chain length of peptide antigens
12/08/2004	EP1444266A4 Use of abalone processing waste
12/08/2004	EP1434886A4 Mid 241 receptor, a novel g-protein coupled receptor
12/08/2004	EP1404428A4 Methods for purifying highly anionic proteins
12/08/2004	EP1141014B1 Insulin-like growth factor (igf) i mutant variant
12/08/2004	EP1125135B1 A complex of a chaperone with beta-amyloid and methods employing this complex
12/08/2004	EP1056858B1 RECOMBINANT ACTIVE HUMAN ZONA PELLUCIDA PROTEIN 3 (hZP3)
12/08/2004	EP1034188A4 Method of designing agonists and antagonists to igf receptor
12/08/2004	EP1027216A4 Bioriented polyethylene film with a high water vapor transmission rate
12/08/2004	EP1015015A4 pRb2/p130 PEPTIDE INHIBITORS OF cdk2 KINASE ACTIVITY
12/08/2004	EP1009767B1 HUMAN DEFENSIN DEF-X, GENE AND DNAc, COMPOSITION CONTAINING SAME AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
12/08/2004	EP0966535B1 Epitopes of the protein pre-m/m of the dengue virus, synthetic peptides
12/08/2004	EP0964740B1 Biotechnical process for the preparation of aspartic acid homo- or copolymers
12/08/2004	EP0833941A4 Polypeptides having a functional domain of interest and methods of identifying and using same

1 ... 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 ... 2916